复发性胸腺瘤的治疗  

Treatment of Recurrent Thymoma

作　　者：刘显平 李晓 李剑锋[1] Xianping LIU;Xiao LI;Jianfeng LI(Department of Thoracic Surgery,Peking University People's Hospital,Beijing 100044,China)

机构地区：[1]北京大学人民医院胸外科,北京100044

出　　处：《中国肺癌杂志》2020年第3期204-210,共7页Chinese Journal of Lung Cancer

摘　　要：胸腺瘤是一种具有恶性潜能的疾病,完整切除后的复发率为10%-30%。复发性胸腺瘤的治疗策略及标准未达成一致,治疗方式包括再次手术治疗、化疗、放疗、靶向治疗及免疫治疗等,至今存在着争议。在这篇综述中,通过回顾既往的文献,总结了复发性胸腺瘤的不同治疗方法的适应证、疗效以及预后,以期给复发性胸腺瘤治疗标准的制定提供一些参考。Thymoma is a potential malignant disease with a recurrence rate of 10%to 30%after complete resection.There is no agreement on the treatment strategy and standard for recurrent thymoma.The treatment methods include reoperation,chemotherapy,radiotherapy,targeted therapy and immunotherapy.In this article,we review the previous literature and summarize the indications,efficacy and prognosis of different treatments for recurrent thymoma,so as to provide some reference for treatment criteria for recurrent thymoma.

关 键 词：复发性胸腺瘤 手术治疗 化疗 放疗 靶向治疗 

分 类 号：R736.3[医药卫生—肿瘤]